- Filed
- May 31, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 10, 2024 | 2.24M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 2.14M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 2.24M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $6K |
| Capex | Q1 2024 · Mar 31, 2023 | $147K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$1.1M |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | $63K |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $2.91M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $5.86M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $14.53M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $36.91M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $37.7M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $37.52M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $37.33M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $373.93M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $386.8M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $410.83M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $424.5M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.25 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.07 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.25 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.07 |
| Net Income | Q1 2024 · Mar 31, 2024 | −$545K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$152K |
| Revenue | Q1 2024 · Mar 31, 2024 | $317K |
| Revenue | Q1 2024 · Mar 31, 2023 | $491K |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $81K |